Transient Cortical Blindness With Leptomeningeal Enhancement After Attempted Peripherally Inserted Central Venous Catheter Placement
Transient cortical blindness is an infrequent complication of endovascular procedures. [1] [2] [3] We describe a patient who developed transient cortical blindness associated with focal leptomeningeal enhancement on contrast-enhanced T1-weighted magnetic resonance imaging (MRI) following attempted placement of a peripherally inserted central venous catheter (PICC).
Report of a Case.
A 57-year-old woman with metastatic carcinoma of the colon, which had spread to the liver and peritoneum, was hospitalized for partial small-bowel obstruction. Placement of a PICC for total parenteral nutrition (TPN) was attempted with inadvertent cannulation of the brachial artery and infusion of 10 mL of nonheparinized normal saline. The catheter was promptly removed; however, the patient began to complain of blurred vision in each eye approximately 15 minutes after the attempted PICC placement. During the procedure, the patient was hypertensive and tachycardic with a blood pressure of 170/120 mm Hg and a heart rate of 120 beats per minute. The patient's blood pressure was controlled with low-dose oral metoprolol. After the procedure, the patient complained of progressive visual loss, headache, and malaise, which progressed to complete binocular visual loss during the ensuing 4 hours. Ophthalmic examination revealed no light perception vision bilaterally and briskly reactive pupils, without a relative afferent pupillary defect. The anterior segment, extraocular motility, and dilated funduscopy findings were normal in each eye. Findings from the remainder of the neurologic examination were otherwise normal.
Contrast-enhanced MRI obtained 4 hours after the onset of visual loss revealed focal leptomeningeal enhancement in the occipital lobes and superior cerebellum (Figure 1 ). Diffusion-weighted images showed no evidence of ischemia, and magnetic resonance angiography demonstrated normal cerebral vasculature.
Lumbar puncture showed an elevated protein level of 119 mg/dL and a normal glucose level of 81 mg/dL with a normal opening pressure. No atypical cells or white blood cells were seen. The results for cerebrospinal fluid cultures and blood cultures were negative. Twentyfour hours after the onset of visual loss, the patient experienced 2 generalized seizures, which were controlled with intravenous dexamethasone and phenytoin. Comment. Transient cortical blindness following vascular intervention has been described primarily after contrast-enhanced coronary, cerebral, and other arterial perfusion studies. [1] [2] [3] Inadvertent arterial entry during venous catheterization has resulted in cortical blindness in 2 prior reports. 4, 5 In both of those patients, arterial infusion of TPN resulted in transient bilateral visual loss with occipital lobe abnormalities on neuroimaging. In the first report, MRI showed leptomeningeal enhancement around the occipital cortices, similar to that seen in our patient, following TPN infusion into the right vertebral artery. The visual symptoms improved in 2 weeks with a residual right homonymous hemianopia. 4 In the second report, a left homonymous hemianopia and vi-sual hallucinations occurred following TPN infusion into the right subclavian artery. This patient experienced sudden bilateral visual loss after the onset of TPN infusion, which improved after several minutes, and flashes of light each time her central line was flushed with normal saline. Ophthalmic examination showed a left homonymous hemianopia that resolved after 3 days. Magnetic resonance imaging showed multifocal infarcts in the occipital and parietal cortices and in the right cerebellum. 5 The mechanisms causing visual loss following contrast and TPN infusion remain unclear. However, several authors have postulated that the hyperosmolarity of these agents may lead to osmotic disruption of the blood-brain barrier and subsequent cortical blindness through direct neurotoxic effects. 6, 7 Experimental studies have demonstrated that hyperosmolar agents induce vasodilation, shrinkage of cerebrovascular endothelial cells, and widened endothelial tight junctions. 8 The focal leptomeningeal enhancement noted on the contrast-enhanced MRI in our patient suggests that disruption of the blood-brain barrier occurred in the vertebrobasilar distribution. It is unclear whether the nonheparinized normal saline rinse disrupted the blood-brain barrier in our patient, but the timing of the visual symptoms with the catheterization of the brachial artery suggests an iatrogenic vascular cause for the patient's symptoms. A possible contrib-uting factor was the patient's elevated blood pressure because hypertensive encephalopathy may cause transient cortical blindness associated with reversible cerebral edema on neuroimaging. 9 Leptomeningeal enhancement may occur from infection, cerebrovascular disorders, neoplasia, inflammatory conditions, and iatrogenic causes 10, 11 (Table) . In our patient, the pattern of radiographic enhancement could have been attributed to carcinomatous meningitis. However, repeat cerebrospinal fluid examinations revealed no atypical cells. Although cerebrospinal fluid cytology is falsely negative in 10% of patients, 12 the rapid resolution of the radiographic and clinical abnormalities makes the diagnosis of carcinomatous meningitis unlikely. Infectious meningitis was also considered in the differen- tial diagnosis, but the patient demonstrated no signs of infection and laboratory studies did not reveal a source of infection. Scattered cerebral infarction from arterial air emboli was unlikely because no evidence of ischemia was detected on a diffusion-weighted MRI.
The timing of cortical blindness in our patient, shortly after inadvertent arterial entry during attempted PICC line placement, and the focal leptomeningeal enhancement on MRI suggest that breakdown of the bloodbrain barrier was iatrogenic. The precise mechanisms underlying this process remain unclear, but we postulate that transient hyperosmolarity and hypertension may have been involved in the pathogenesis of our patient's symptoms. 
A 70-year-old white woman was referred for evaluation for a 3-day history of visual loss. The medical history was significant for myelodysplastic syndrome that converted to acute myeloid leukemia 4 months prior to the onset of her visual symptoms. The patient had been treated with a course of chemotherapy which was completed 19 days prior to her initial visit. During chemotherapy, she developed Klebsiella pneumoniae, which was treated with piperacillintazobactam, ciprofloxacin hydrochloride, and vancomycin hydrochloride. One day prior to the onset of visual symptoms, blood cultures grew vancomycin-resistant Enterococcus faecium and she was started on a regimen of linezolid.
On examination, visual acuity was hand motion in both eyes. At the bedside, the portable slitlamp examination demonstrated mild (1ϩ) cells and flare in the aqueous of both eyes and a small fibrin clot on the surface of both crystalline lenses. The funduscopic examination revealed a hazy view due to significant vitritis in both eyes. The peripheral retina appeared white with nonperfused vessels.
A pars plana vitreous aspirate was performed in both eyes. Samples were sent for gram stain, culture, and polymerase chain reaction studies. Vancomycin (1 mg/0.1 mL) and amikacin sulfate (400 µg/0.1 mL) were injected into the vitreous cavity of both eyes; the patient was allergic to ceftazidime sodium. Two days after the vitreous tap, vitreous cultures from both eyes were positive for Fusarium species. The blood cultures (drawn 1 day after the vitreous tap) became positive for organisms 3 days later, and biopsy results from a 2 ϫ 2-cm skin lesion with white-yellow discharge (performed 3 days after the vitreous tap) were also positive for Fusarium species post mortem. Two days after the vitreous tap, Amphotericin B (5 µg/ 0.1 mL) was injected into the vitreous cavity of both eyes and the patient was started on a regimen of intravenous amphotericin B (0.7 mg/kg per day) and oral fluconazole (400 mg/d). The following day, the patient died from multiorgan failure. Post mortem, the vitreous and blood fungal polymerase chain reaction assay results showed both Fusarium species and Candida glabrata (Figure) . 
